Capital International, Inc./CA/ - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital International, Inc./CA/ ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$329,573
-89.9%
20,407
-74.0%
0.01%
-89.8%
Q2 2023$3,251,691
-37.9%
78,354
-10.0%
0.06%
-43.8%
Q1 2023$5,236,089
-13.0%
87,065
+6.2%
0.10%
-19.2%
Q4 2022$6,015,434
-6.1%
82,010
-2.8%
0.13%
-9.1%
Q3 2022$6,408,000
-23.2%
84,344
-29.7%
0.14%
+23.3%
Q2 2022$8,341,000
-16.4%
120,020
-0.3%
0.12%
+3.6%
Q1 2022$9,976,000
-13.4%
120,416
-21.5%
0.11%
+4.7%
Q4 2021$11,514,000
-31.4%
153,357
+6.2%
0.11%
-34.0%
Q3 2021$16,776,000
-49.2%
144,410
-2.9%
0.16%
-44.9%
Q2 2021$33,006,000
+109.4%
148,798
+24.8%
0.29%
+101.4%
Q1 2021$15,765,000
-26.3%
119,271
-3.6%
0.15%
-26.3%
Q4 2020$21,398,000
+61.8%
123,662
+4.1%
0.20%
+35.6%
Q3 2020$13,229,000
+225.4%
118,844
+73.4%
0.15%
+192.0%
Q2 2020$4,065,000
+12.0%
68,548
+27.2%
0.05%
-18.0%
Q1 2020$3,629,00053,8850.06%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders